Justicia insularis Improves the in vitro Survival and Development of Ovine Preantral Follicles Enclosed in Ovarian Tissue
Journal: Journal of Pharmacy and Pharmacology (Vol.5, No. 9)Publication Date: 2017-09-15
Authors : Gildas Tetaping Mbemya; Denise Damasceno Guerreiro; Nathalie Jiatsa Donfack; et al;
Page : 668-680
Keywords : ;
Abstract
Objectives: Evaluating the addition effect of J. insularis extract and FSH on the survival, activation and ROS production after in vitro culture of ovine preantral follicles enclosed in ovarian tissue. Methods: In the first experiment, ovarian fragments were fixed (non-cultured control) or in vitro cultured in α-MEM+ (cultured control), α-MEM+ supplemented with FSH 50 ng/mL, or in α-MEM+ supplemented with J. insularis (JUS0.3; 1.25 or 5 mg/mL) for 1 or 7 days, at 39°C, 5% CO2. In the second experiment, fragments were fixed or cultured in α-MEM+ supplemented with anethole 300 μg/mL + FSH 50 ng/mL or in α-MEM+ supplemented with anethole 300 μg/mL + 0.3 mg/mL JUS. Key findings: JUS0.3 was the only treatment that maintained the percentage of morphologically normal follicles similar to non-cultured control even after 7 days of culture. After 7 days of culture, a higher (p < 0.05) percentage of developing follicles was observed in JUS5 treatment compared with the other treatments except JUS1.25. In the second experiment, FSH maintained the percentage of normal follicles and promoted activation of primordial follicles. A reduction (p < 0.05) of stromal cell density was observed in MEM++ANE supplemented with JUS or FSH. Conclusions: J. insularis in a concentration-dependent manner maintained the levels of ROS and improved in vitro follicular survival and activation of ovine primordial follicles.
Other Latest Articles
- Bioequivalence of Two Brands of Valsartan 80 mg Coated Breakable Tablets in 15 Healthy Algerian Volunteers: A Pilot Study
- Anti-promastigote Activity of the Amazon Plants
- On the Role of Intestinal Microbiota in Patients with Cognitive Decline
- Impact of a Pilot, Pharmacy-Led Tobacco Cessation Medication Protocol at Discharge in a Community Hospital
- Temporary Dysarthria Induced by Irinotecan-Case Report of This Rare Adverse Event
Last modified: 2022-07-05 10:06:03